The FDA granted fast track designation to SAR446597, an intravitreal gene therapy for the treatment of geographic atrophy due to age-related macular degeneration, according to a press release from ...

The US Food and Drug Administration (FDA) recently granted fast track designation to Sanofi’s SAR446597 for the treatment of geographic atrophy (GA). 1 ...

Sanofi SNY has announced that the FDA has granted a fast-track designation to its one-time intravitreal gene therapy, SAR446597, for the treatment of geographic atrophy (GA) due to age-related macular ...

Sanofi said SAR446597, its treatment for geographic atrophy due to age-related macular degeneration, was granted fast-track designation by the Food and Drug Administration. The French drugmaker said ...

Age-Related Macular Degeneration Market Epidemiology Report 2025-2035: Drugs Pipeline, Therapies, and Forecast The report provides a detail ...

Sanofi's SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration <li /> Designat ...

The field of gerontology is witnessing a significant demographic transition, as the global population of individuals aged 65 ...

Objective: To investigate the risk of age-related macular degeneration (AMD) in association with optic disc drusen (ODD). Design: Observational, cross-sectional study.

Background/Aims Age-related macular degeneration (AMD) is the main cause of visual impairment and blindness in Europe. A further increase in the number of affected persons is expected and current ...

Macular degeneration articles from across Nature Portfolio Macular degeneration usually refers to the age-related degenerative changes in the retina that can result in loss of central vision.

A combination of genetics and drinking instant coffee is linked to an increased risk of developing a common form of age-related macular degeneration, a new study has found.